Second Phase 3 clinical trial again shows dupilumab lessens disease in COPD patients with type 2 inflammation

UAB is already a national leader in clinical trials. Here is how it plans to extend the benefits to even more Alabamians.

Revolutionizing Sales: New research shows how AI is shaping the future of sales strategies